Viewing Study NCT04425018


Ignite Creation Date: 2025-12-25 @ 4:57 AM
Ignite Modification Date: 2026-03-03 @ 9:15 PM
Study NCT ID: NCT04425018
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-18
First Post: 2020-04-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: MARGetuximab Or Trastuzumab (MARGOT)
Sponsor: Dana-Farber Cancer Institute
Organization: